Form 8-K - Current report:
SEC Accession No. 0001104659-20-009835
Filing Date
2020-02-03
Accepted
2020-02-03 17:00:45
Documents
5
Period of Report
2020-02-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm206457-1_8k.htm 8-K 21229
2 EXHIBIT 99.1 tm206457d1_ex99-1.htm EX-99.1 591789
3 EXHIBIT 99.2 tm206457d1_ex99-2.htm EX-99.2 3106
4 GRAPHIC tm206457d1_ex99-1img001.jpg GRAPHIC 4301
5 GRAPHIC tm206457d1_ex99-2img001.jpg GRAPHIC 4301
  Complete submission text file 0001104659-20-009835.txt   629653
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Filer) CIK: 0001069899 (see all company filings)

EIN.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-36410 | Film No.: 20569414
SIC: 2834 Pharmaceutical Preparations